Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Coughlin Timothy, Director. Officer active across 5 companies, notably Travere Therapeutics, Inc.. In total, 20 filings have been logged. Split: 1 buy · 2 sells. Total volume traded: €111k. Activity tracked since 14 May 2021. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Coughlin Timothy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
COUGHLIN TIMOTHY is Administrateur and has been associated with Travere Therapeutics, Inc., ADC Therapeutics SA, aTYR PHARMA INC, Fate Therapeutics INC and Vir Biotechnology, Inc. The declarant has 20 filings in total, and within the sampled recent filings the period runs from 2021-05-18 to 2026-06-16, with buy volume of EUR 80754 and sell volume of EUR 30531, and the modal transaction nature is Attribution.